http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 17 Jul 2026 16:16:30 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Equity+Offerings/Q32+Bio+%28QTTB%29+files+for+6.875M+share+offering+by+selling+stockholders/26784535.html <p>Q32 Bio (NASDAQ: QTTB) filed for up to 6,875,000 share offering by selling stockholders.</p> http://www.streetinsider.com/Equity+Offerings/Q32+Bio+%28QTTB%29+files+for+6.875M+share+offering+by+selling+stockholders/26784535.html Fri, 17 Jul 2026 16:16:30 -0400 QTTB http://www.streetinsider.com/Corporate+News/Q32+Bio+%28QTTB%29+files+for+6.875M+share+offering+by+selling+stockholders/26784535.html <p>Q32 Bio (NASDAQ: QTTB) filed for up to 6,875,000 share offering by selling stockholders.</p> http://www.streetinsider.com/Corporate+News/Q32+Bio+%28QTTB%29+files+for+6.875M+share+offering+by+selling+stockholders/26784535.html Fri, 17 Jul 2026 16:16:30 -0400 QTTB http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Q32+Bio+Inc.+++++++++++++++++++++++++/26784492.html si-local-file:///var/storage/secattach/20260717/26784492.html http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Q32+Bio+Inc.+++++++++++++++++++++++++/26784492.html Fri, 17 Jul 2026 16:15:00 -0400 O.30978114 QTTB http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Q32+Bio+Inc.+++++++++++++++++++++++++/26784492.html si-local-file:///var/storage/secattach/20260717/26784492.html http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Q32+Bio+Inc.+++++++++++++++++++++++++/26784492.html Fri, 17 Jul 2026 16:15:00 -0400 O.30978114 QTTB http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Q32+Bio+Inc.++++++++++++++For%3A+Jul+14/26774983.html si-local-file:///var/storage/secattach/20260715/26774983.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Q32+Bio+Inc.++++++++++++++For%3A+Jul+14/26774983.html Wed, 15 Jul 2026 17:19:00 -0400 O.30978114 QTTB http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Q32+Bio+Inc.++++++++++++++For%3A+Jul+14/26774983.html si-local-file:///var/storage/secattach/20260715/26774983.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Q32+Bio+Inc.++++++++++++++For%3A+Jul+14/26774983.html Wed, 15 Jul 2026 17:19:00 -0400 O.30978114 QTTB http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Q32+Bio+Inc.+++++++++++++++++++++++++/26774933.html si-local-file:///var/storage/secattach/20260715/26774933.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Q32+Bio+Inc.+++++++++++++++++++++++++/26774933.html Wed, 15 Jul 2026 17:11:00 -0400 O.30978114 QTTB http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Q32+Bio+Inc.+++++++++++++++++++++++++/26774933.html si-local-file:///var/storage/secattach/20260715/26774933.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Q32+Bio+Inc.+++++++++++++++++++++++++/26774933.html Wed, 15 Jul 2026 17:11:00 -0400 O.30978114 QTTB http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html <p>Q32 Bio Inc. (Nasdaq: QTTB), a clinical-stage biotechnology company based in Waltham, Mass., has priced an underwritten public offering of common stock and pre-funded warrants expected to raise approximately $200 million in gross proceeds.</p> <p>The offering includes 6,027,399 shares of common stock at $18.25 per share and pre-funded warrants to purchase 4,931,506 shares at $18.2499 per warrant. Q32 Bio has also granted underwriters a 30-day option to purchase up to an additional 1,643,835 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 16, 2026.</p> <p>Morgan Stanley, Jefferies, and Cantor are http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html Tue, 14 Jul 2026 22:59:45 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html <p>Q32 Bio Inc. (Nasdaq: QTTB), a clinical-stage biotechnology company based in Waltham, Mass., has priced an underwritten public offering of common stock and pre-funded warrants expected to raise approximately $200 million in gross proceeds.</p> <p>The offering includes 6,027,399 shares of common stock at $18.25 per share and pre-funded warrants to purchase 4,931,506 shares at $18.2499 per warrant. Q32 Bio has also granted underwriters a 30-day option to purchase up to an additional 1,643,835 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 16, 2026.</p> <p>Morgan Stanley, Jefferies, and Cantor are http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html Tue, 14 Jul 2026 22:59:45 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html <p>Q32 Bio Inc. (Nasdaq: QTTB), a clinical-stage biotechnology company based in Waltham, Mass., has priced an underwritten public offering of common stock and pre-funded warrants expected to raise approximately $200 million in gross proceeds.</p> <p>The offering includes 6,027,399 shares of common stock at $18.25 per share and pre-funded warrants to purchase 4,931,506 shares at $18.2499 per warrant. Q32 Bio has also granted underwriters a 30-day option to purchase up to an additional 1,643,835 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 16, 2026.</p> <p>Morgan Stanley, Jefferies, and Cantor are http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html Tue, 14 Jul 2026 22:59:45 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html <p>Q32 Bio Inc. (Nasdaq: QTTB), a clinical-stage biotechnology company based in Waltham, Mass., has priced an underwritten public offering of common stock and pre-funded warrants expected to raise approximately $200 million in gross proceeds.</p> <p>The offering includes 6,027,399 shares of common stock at $18.25 per share and pre-funded warrants to purchase 4,931,506 shares at $18.2499 per warrant. Q32 Bio has also granted underwriters a 30-day option to purchase up to an additional 1,643,835 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 16, 2026.</p> <p>Morgan Stanley, Jefferies, and Cantor are http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html Tue, 14 Jul 2026 22:59:45 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html <p>Q32 Bio Inc. (Nasdaq: QTTB), a clinical-stage biotechnology company based in Waltham, Mass., has priced an underwritten public offering of common stock and pre-funded warrants expected to raise approximately $200 million in gross proceeds.</p> <p>The offering includes 6,027,399 shares of common stock at $18.25 per share and pre-funded warrants to purchase 4,931,506 shares at $18.2499 per warrant. Q32 Bio has also granted underwriters a 30-day option to purchase up to an additional 1,643,835 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 16, 2026.</p> <p>Morgan Stanley, Jefferies, and Cantor are http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html Tue, 14 Jul 2026 22:59:45 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html <p>Q32 Bio Inc. (Nasdaq: QTTB), a clinical-stage biotechnology company based in Waltham, Mass., has priced an underwritten public offering of common stock and pre-funded warrants expected to raise approximately $200 million in gross proceeds.</p> <p>The offering includes 6,027,399 shares of common stock at $18.25 per share and pre-funded warrants to purchase 4,931,506 shares at $18.2499 per warrant. Q32 Bio has also granted underwriters a 30-day option to purchase up to an additional 1,643,835 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 16, 2026.</p> <p>Morgan Stanley, Jefferies, and Cantor are http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html Tue, 14 Jul 2026 22:59:45 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html <p>Q32 Bio Inc. (Nasdaq: QTTB), a clinical-stage biotechnology company based in Waltham, Mass., has priced an underwritten public offering of common stock and pre-funded warrants expected to raise approximately $200 million in gross proceeds.</p> <p>The offering includes 6,027,399 shares of common stock at $18.25 per share and pre-funded warrants to purchase 4,931,506 shares at $18.2499 per warrant. Q32 Bio has also granted underwriters a 30-day option to purchase up to an additional 1,643,835 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 16, 2026.</p> <p>Morgan Stanley, Jefferies, and Cantor are http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html Tue, 14 Jul 2026 22:59:45 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html <p>Q32 Bio Inc. (Nasdaq: QTTB), a clinical-stage biotechnology company based in Waltham, Mass., has priced an underwritten public offering of common stock and pre-funded warrants expected to raise approximately $200 million in gross proceeds.</p> <p>The offering includes 6,027,399 shares of common stock at $18.25 per share and pre-funded warrants to purchase 4,931,506 shares at $18.2499 per warrant. Q32 Bio has also granted underwriters a 30-day option to purchase up to an additional 1,643,835 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 16, 2026.</p> <p>Morgan Stanley, Jefferies, and Cantor are http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html Tue, 14 Jul 2026 22:59:45 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html <p>Q32 Bio Inc. (Nasdaq: QTTB), a clinical-stage biotechnology company based in Waltham, Mass., has priced an underwritten public offering of common stock and pre-funded warrants expected to raise approximately $200 million in gross proceeds.</p> <p>The offering includes 6,027,399 shares of common stock at $18.25 per share and pre-funded warrants to purchase 4,931,506 shares at $18.2499 per warrant. Q32 Bio has also granted underwriters a 30-day option to purchase up to an additional 1,643,835 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 16, 2026.</p> <p>Morgan Stanley, Jefferies, and Cantor are http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html Tue, 14 Jul 2026 22:59:45 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html <p>Q32 Bio Inc. (Nasdaq: QTTB), a clinical-stage biotechnology company based in Waltham, Mass., has priced an underwritten public offering of common stock and pre-funded warrants expected to raise approximately $200 million in gross proceeds.</p> <p>The offering includes 6,027,399 shares of common stock at $18.25 per share and pre-funded warrants to purchase 4,931,506 shares at $18.2499 per warrant. Q32 Bio has also granted underwriters a 30-day option to purchase up to an additional 1,643,835 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 16, 2026.</p> <p>Morgan Stanley, Jefferies, and Cantor are http://www.streetinsider.com/Equity+Offerings/Q32+Bio+prices+%24200+million+stock+offering+at+%2418.25+per+share/26769529.html Tue, 14 Jul 2026 22:59:45 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.walham" idsrc="xmltag.org" >WALTHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>July 14, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio Inc.</span> (Nasdaq: QTTB), ("<span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio</span>") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today announced the pricing of an underwritten public offering of 6,027,399 shares of its common stock at a public offering price of <money>$18.25</money> per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 4,931,506 shares of its common stock at a public offering price of <money>$18.2499</money> per pre-funded warrant, which http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html Tue, 14 Jul 2026 22:58:00 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.walham" idsrc="xmltag.org" >WALTHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>July 14, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio Inc.</span> (Nasdaq: QTTB), ("<span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio</span>") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today announced the pricing of an underwritten public offering of 6,027,399 shares of its common stock at a public offering price of <money>$18.25</money> per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 4,931,506 shares of its common stock at a public offering price of <money>$18.2499</money> per pre-funded warrant, which http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html Tue, 14 Jul 2026 22:58:00 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.walham" idsrc="xmltag.org" >WALTHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>July 14, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio Inc.</span> (Nasdaq: QTTB), ("<span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio</span>") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today announced the pricing of an underwritten public offering of 6,027,399 shares of its common stock at a public offering price of <money>$18.25</money> per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 4,931,506 shares of its common stock at a public offering price of <money>$18.2499</money> per pre-funded warrant, which http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html Tue, 14 Jul 2026 22:58:00 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.walham" idsrc="xmltag.org" >WALTHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>July 14, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio Inc.</span> (Nasdaq: QTTB), ("<span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio</span>") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today announced the pricing of an underwritten public offering of 6,027,399 shares of its common stock at a public offering price of <money>$18.25</money> per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 4,931,506 shares of its common stock at a public offering price of <money>$18.2499</money> per pre-funded warrant, which http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html Tue, 14 Jul 2026 22:58:00 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.walham" idsrc="xmltag.org" >WALTHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>July 14, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio Inc.</span> (Nasdaq: QTTB), ("<span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio</span>") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today announced the pricing of an underwritten public offering of 6,027,399 shares of its common stock at a public offering price of <money>$18.25</money> per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 4,931,506 shares of its common stock at a public offering price of <money>$18.2499</money> per pre-funded warrant, which http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html Tue, 14 Jul 2026 22:58:00 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.walham" idsrc="xmltag.org" >WALTHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>July 14, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio Inc.</span> (Nasdaq: QTTB), ("<span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio</span>") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today announced the pricing of an underwritten public offering of 6,027,399 shares of its common stock at a public offering price of <money>$18.25</money> per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 4,931,506 shares of its common stock at a public offering price of <money>$18.2499</money> per pre-funded warrant, which http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html Tue, 14 Jul 2026 22:58:00 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.walham" idsrc="xmltag.org" >WALTHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>July 14, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio Inc.</span> (Nasdaq: QTTB), ("<span value="NASDAQ-NMS:QTTB" idsrc="xmltag.org" >Q32 Bio</span>") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today announced the pricing of an underwritten public offering of 6,027,399 shares of its common stock at a public offering price of <money>$18.25</money> per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 4,931,506 shares of its common stock at a public offering price of <money>$18.2499</money> per pre-funded warrant, which http://www.streetinsider.com/Press+Releases/Q32+Bio+Announces+Pricing+of+%24200+Million+Public+Offering+of+Common+Stock+and+Pre-Funded+Warrants/26769528.html Tue, 14 Jul 2026 22:58:00 -0400 A.03080680 A.14860339 A.15776824 A.50202486 O.00047285 O.30978114 O.51342512 O.51342537 O.51342612 QTTB